These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4555640)

  • 41. [Bacteriocins of Enterobacter liquefaciens. Taxonomic interest of their study].
    Hamon Y; Le Minor L; Peron Y
    C R Acad Hebd Seances Acad Sci D; 1970 Feb; 270(6):886-9. PubMed ID: 4984959
    [No Abstract]   [Full Text] [Related]  

  • 42. State of the art: typing of Serratia marcescens.
    Pitt TL
    J Hosp Infect; 1982 Mar; 3(1):9-14. PubMed ID: 6177740
    [No Abstract]   [Full Text] [Related]  

  • 43. [O-serotypes, biochemical properties and antimicrobial susceptibilities of Serratia marcescens isolated from clinical specimens (2nd report)].
    Marumo K; Takeuchi T; Aoki Y
    Rinsho Byori; 1990 Sep; 38(9):1077-82. PubMed ID: 1700174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiology and susceptibility of serratia marcescens in a large general hospital over an 8-year period.
    Hejazi A; Aucken HM; Falkiner FR
    J Hosp Infect; 2000 May; 45(1):42-6. PubMed ID: 10833342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bacteriocin 28b, a chromosomally encoded bacteriocin produced by most Serratia marcescens biotypes.
    Guasch JF; Enfedaque J; Ferrer S; Gargallo D; Regué M
    Res Microbiol; 1995; 146(6):477-83. PubMed ID: 8525064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiological Typing of Serratia marcescens Isolates by Whole-Genome Multilocus Sequence Typing.
    Rossen JWA; Dombrecht J; Vanfleteren D; De Bruyne K; van Belkum A; Rosema S; Lokate M; Bathoorn E; Reuter S; Grundmann H; Ertel J; Higgins PG; Seifert H
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30728192
    [No Abstract]   [Full Text] [Related]  

  • 47. Differential activity of bacteriocins and cefotaxime against Serratia marcescens clinical isolate SMG40 and its pigmented variant.
    Gratia JP; Crenier L
    Zentralbl Bakteriol; 1992 Feb; 276(3):340-6. PubMed ID: 1576403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunochemical characterization of two new O serotypes of Serratia marcescens (O27 and O28).
    Aucken HM; Wilkinson SG; Pitt TL
    FEMS Microbiol Lett; 1996 Apr; 138(1):77-82. PubMed ID: 8674974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of RAPD-PCR as a typing method for Serratia marcescens.
    Hejazi A; Keane CT; Falkiner FR
    J Med Microbiol; 1997 Nov; 46(11):913-9. PubMed ID: 9368531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of Serratia marcescens isolates from subgingival biofilm, extraoral infections and environment by prodigiosin production, serotyping, and genotyping.
    Barbosa FC; Irino K; Carbonell GV; Mayer MP
    Oral Microbiol Immunol; 2006 Feb; 21(1):53-60. PubMed ID: 16390342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serotyping of Serratia marcescens: simplified tube O-agglutination test and comparison with other serological procedures.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):474-93. PubMed ID: 396741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.
    Wilfert JN; Barrett FF; Ewing WH; Finland M; Kass EH
    Appl Microbiol; 1970 Feb; 19(2):345-52. PubMed ID: 4314379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of Serratia outbreaks in hospital.
    Farmer JJ; Davis BR; Hickman FW; Presley DB; Bodey GP; Negut M; Bobo RA
    Lancet; 1976 Aug; 2(7983):455-9. PubMed ID: 73753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of strains of Serratia marcescens isolated from neonates with strains isolated from sporadic and epidemic infections in adults.
    Gaston MA; Hoffman PN; Pitt TL
    J Hosp Infect; 1986 Jul; 8(1):86-95. PubMed ID: 2875106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [O-serotypes, biotypes and antimicrobial susceptibilities of Serratia marcescens isolates from clinical specimens: 4th report].
    Marumo K; Nakamura Y; Fukuda S
    Rinsho Byori; 1995 Nov; 43(11):1140-6. PubMed ID: 8551678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study on serotyping, phage typing and drug resistance of Serratia marcescens isolated from clinical specimens (author's transl)].
    Morishita H
    Nihon Hinyokika Gakkai Zasshi; 1980 Nov; 71(11):1313-27. PubMed ID: 7007698
    [No Abstract]   [Full Text] [Related]  

  • 57. Properties and characteristics of a bacteriocin from Serratia marcescens.
    Foulds JD; Shemin D
    J Bacteriol; 1969 Sep; 99(3):655-60. PubMed ID: 4905530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bacteriophage typing of clinically isolated Serratia marcescens.
    Hamilton RL; Brown WJ
    Appl Microbiol; 1972 Dec; 24(6):899-906. PubMed ID: 4568252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Serratia marcescens infections in a hospital: typing of isolated strains].
    Yde M
    Arch Belg; 1989; 47(5-6):189-210. PubMed ID: 2700064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Sero-types and drug sensitivity of Serratia marcescens isolated from pathological specimens, with special reference to hospital infections. II. (author's transl)].
    Yama H; Yamada K; Tsujimoto T
    Jpn J Antibiot; 1979 Jun; 32(6):661-7. PubMed ID: 381707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.